Quince Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $168 | $0 |
Gross Profit | -35 | -32 | 84 | -86 |
EBITDA | -15,947 | -14,858 | -10,093 | -8,460 |
EBIT | -15,982 | -14,890 | -10,109 | -8,546 |
Net Income | -16,049 | -15,030 | -12,458 | -5,492 |
Net Change In Cash | 0 | 0 | 168 | 0 |
Free Cash Flow | -5,194 | -9,749 | -7,685 | -7,306 |
Cash | 16,826 | 7,771 | 6,212 | 2,675 |
Basic Shares | 46,686 | 43,941 | 43,262 | 43,164 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -186 | -322 | -175 | -344 |
EBITDA | -56,555 | -31,260 | -49,886 | -89,974 |
EBIT | -56,741 | -31,582 | -50,090 | -90,318 |
Net Income | -56,828 | -31,385 | -51,660 | -89,945 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -25,329 | |||
Free Cash Flow | -32,161 | -18,452 | -44,171 | -63,112 |
Cash | 6,212 | 20,752 | 44,579 | 69,724 |
Basic Shares | 43,262 | 37,237 | 33,496 | 29,718 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.34 |
2024-12-31 | -$0.28 |
